Biopharmaceutical companies are working across the industry and around the world to meet the global demand for COVID-19 vaccines. Companies have continued to ramp up their efforts to source needed supplies, identify manufacturing efficiencies and increase manufacturing capacity through partnerships in the United States and around the globe to get as many COVID-19 vaccine shots in arms as possible.
